Stemlab’s Cordvida deal attracts in-depth probe in Portugal
MLex Summary: Biotechnology company Stemlab's planned acquisition of exclusive control over Cordvida Portugal and its unit Stamcriovitae will come under a full probe, Portugal's competition authority said on Monday, citing its serious doubts. Cordvida...To view the full article, register now.
Already a subscriber? Click here to view full article